Mark Sulkowski

439 total citations
6 papers, 310 citations indexed

About

Mark Sulkowski is a scholar working on Epidemiology, Rheumatology and Hepatology. According to data from OpenAlex, Mark Sulkowski has authored 6 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Rheumatology and 2 papers in Hepatology. Recurrent topics in Mark Sulkowski's work include Hepatitis C virus research (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Hepatitis B Virus Studies (1 paper). Mark Sulkowski is often cited by papers focused on Hepatitis C virus research (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Hepatitis B Virus Studies (1 paper). Mark Sulkowski collaborates with scholars based in United States, Switzerland and Denmark. Mark Sulkowski's co-authors include Nezam H. Afdhal, Jacquie Astemborski, Shruti H. Mehta, David L. Thomas, Thomas Kelleher, R. Bhaskar, Richard E. Moore, Gregory D. Kirk, Michael Torbenson and Richard D. Moore and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

Mark Sulkowski

6 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Sulkowski United States	4	268	257	20	20	16	6	310
Annika Kau Germany	3	371 1.4×	372 1.4×	9 0.5×	43 2.1×	7 0.4×	4	410
Fernanda Branco Brazil	8	165 0.6×	163 0.6×	29 1.4×	14 0.7×	9 0.6×	11	252
Rob Myers France	9	327 1.2×	311 1.2×	25 1.3×	18 0.9×	3 0.2×	20	363
Lorena De Moliner Italy	10	366 1.4×	374 1.5×	23 1.1×	17 0.8×	6 0.4×	13	429
Caterina Furlan Italy	10	270 1.0×	264 1.0×	6 0.3×	23 1.1×	4 0.3×	18	325
Rousselet Mc France	4	259 1.0×	246 1.0×	11 0.6×	8 0.4×	4 0.3×	7	305
Nancy Fryzek United States	5	238 0.9×	253 1.0×	11 0.6×	10 0.5×	5 0.3×	7	316
Mihály Makara Hungary	7	163 0.6×	179 0.7×	4 0.2×	21 1.1×	10 0.6×	35	228
Tomoo Kobayashi Japan	8	176 0.7×	173 0.7×	30 1.5×	10 0.5×	9 0.6×	23	253
Leona Osawa Japan	10	265 1.0×	234 0.9×	14 0.7×	19 0.9×	3 0.2×	33	319

Countries citing papers authored by Mark Sulkowski

Since Specialization

Citations

This map shows the geographic impact of Mark Sulkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sulkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sulkowski more than expected).

Fields of papers citing papers by Mark Sulkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sulkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sulkowski. The network helps show where Mark Sulkowski may publish in the future.

Co-authorship network of co-authors of Mark Sulkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sulkowski. A scholar is included among the top collaborators of Mark Sulkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sulkowski. Mark Sulkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Sulkowski, Mark, Stuart K. Roberts, Nezam H. Afdhal, et al.. (2012). 594 Ribavirin Dose Modification in Treatment-NaïVE and Previously Treated Patients Who Received Telaprevir Combination Treatment: No Impact on Sustained Virologic Response in Phase 3 Studies. Gastroenterology. 142(5). S–919. 3 indexed citations

2.

Sulkowski, Mark, Fred Poordad, Michael P. Manns, et al.. (2011). Anemia During Treatment With Peginterferon Alfa-2B/Ribavirin With or Without Boceprevir is Associated With Higher SVR Rates: Analysis of Previously Untreated and Previous-Treatment-Failure Patients. Gastroenterology. 140(5). S–941. 9 indexed citations

3.

Sulkowski, Mark, M. Shiffman, Jonathan McCone, et al.. (2009). 126 HEMOGLOBIN DECLINE IS ASSOCIATED WITH SVR AMONG HCV GENOTYPE 1-INFECTED PERSONS TREATED WITH PEGINTERFERON (PEG)/RIBAVIRIN (RBV): ANALYSIS FROM THE IDEAL STUDY. Journal of Hepatology. 50. S51–S52. 3 indexed citations

4.

Kirk, Gregory D., Jacquie Astemborski, Shruti H. Mehta, et al.. (2009). Assessment of Liver Fibrosis by Transient Elastography in Persons with Hepatitis C Virus Infection or HIV–Hepatitis C Virus Coinfection. Clinical Infectious Diseases. 48(7). 963–972. 119 indexed citations

5.

Kelleher, Thomas, Shruti H. Mehta, R. Bhaskar, et al.. (2005). Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index. Journal of Hepatology. 43(1). 78–84. 171 indexed citations

6.

Chabowski, Adrian, M Sulkowska, Mark Sulkowski, et al.. (2001). Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.. PubMed. 39(2). 153–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact